Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 13, 2026
Sabesp (SBS) Reports Q2 2026 Earnings: Net Income Declines 31.4%

Sabesp (SBS) Reports Q2 2026 Earnings: Net Income Declines 31.4%

Key Takeaways

  • Reported net income came in at R$1.46 billion for Q2 2026, down 31.4% year over year and just below the R$1.53 billion consensus compiled by LSEG.
  • Total net revenue rose 13.9% to R$10.21 billion, while adjusted net revenue grew 6.7% to R$6.01 billion.
  • Reported EBITDA held roughly flat at R$3.91 billion; adjusted EBITDA declined 3.2% to R$3.50 billion, with the adjusted margin narrowing to 58.3%.
  • Net financial expenses widened sharply to negative R$1.02 billion from negative R$118 million a year earlier, reflecting higher debt.
  • Net debt reached R$34.0 billion at the end of June, with leverage at 2.5 times net debt to EBITDA.
  • First-half capital expenditures rose 15.6% to about R$7.5 billion, keeping the company on track for its roughly R$20 billion 2026 investment plan.

Why These Results Matter

Sabesp is Latin America’s largest water and sewage utility and the primary sanitation provider for São Paulo state. Its quarterly updates draw attention because the company is in the middle of a multi-year universalization program that will require billions of reais in spending through 2029. The Q2 2026 numbers are therefore less about headline growth and more about what they show regarding margins, financing costs, and the speed of infrastructure delivery. In my view, investors are also tracking how tariff adjustments, subsidized social tariffs, and rising leverage interact as the investment cycle intensifies.

Breaking Down the Reported Results

Sabesp released its second-quarter 2026 results on August 12, after the close of U.S. markets, for the period ended June 30, 2026.

Total net revenue, including construction activity, rose 13.9% year over year to R$10.21 billion. Adjusted net revenue advanced 6.7% to R$6.01 billion, while reported revenue from sanitation services reached R$6.59 billion, up 12.1% and slightly above the R$6.34 billion consensus compiled by LSEG. The top line benefited from an 8.7% increase in net prices after tariff adjustments and a 1.0% contribution from new connections, partially offset by milder weather and a shift in the customer mix toward subsidized social tariffs.

Reported net income fell 31.4% to R$1.46 billion from R$2.14 billion a year earlier, landing just below the R$1.53 billion analyst estimate. Adjusted net income declined 41.2% to R$1.15 billion, pressured by a 24.5% rise in operating costs and expenses and a much larger negative financial result of R$1.02 billion, compared with a R$118 million loss a year earlier. The company also noted that the year-ago adjusted comparison was helped by roughly R$200 million in provision reversals and judicial wins.

Reported EBITDA was essentially stable at R$3.91 billion. Adjusted EBITDA decreased 3.2% to R$3.50 billion, and the adjusted EBITDA margin narrowed to 58.3% from 64.2%. Adjusted earnings per share were R$0.33, down from R$0.57 a year earlier, reflecting the five-for-one stock split approved in April 2026. Second-quarter capital expenditures reached R$3.73 billion, up 3.6% year over year, bringing first-half investment to about R$7.5 billion. I also checked sector comparisons using Tickeron’s AI Screener to see how the stock stacks up against other utilities on fundamentals and recent performance.

Market Reaction and Investor Focus

Because Sabesp reported after the U.S. market close on August 12, the clearest ADR reaction will emerge during the August 13 trading session and the company’s earnings call. Since reported net income landed close to consensus, the results are unlikely to be viewed as a major headline surprise. Instead, attention is likely to center on the decline in adjusted profitability, the jump in financing costs, and the increase in leverage to 2.5 times net debt to EBITDA.

Heading into the report, analysts had projected net income of R$1.53 billion and EBITDA of R$3.76 billion, according to LSEG. The modest gap between expectations and reported figures suggests investors will pay more attention to the balance sheet and the pace of capital deployment than to a simple earnings beat or miss.

Forward Outlook and Factors to Monitor

Investors will be watching whether Sabesp can maintain its investment rhythm while containing leverage. The company is targeting roughly R$20 billion in capital expenditures for 2026, part of a plan to meet universal water and sewage access goals in São Paulo state by 2029. With net debt at R$34.0 billion and leverage at 2.5 times, the pace and funding mix of future capex will remain central to the investment case.

Tariff dynamics are another key variable. Revenue continues to benefit from regulated tariff adjustments, but the expansion of subsidized social tariffs is diluting the revenue mix. Management is also advancing regulatory discussions, including a commercial discount policy for large clients and new regulatory accounting principles, which could influence revenue and margins in the second half of the year.

Cost control, energy expenses, and the ramp-up of major projects such as the Integra Tietê program will also matter. Finally, any update on potential participation in the Copasa privatization process, likely in partnership with Equatorial, and progress on operational efficiency initiatives could shape the outlook beyond the quarterly numbers. From what I see, these elements will determine how the story develops from here.

Enhancing Analysis with AI Tools

In my own research on utilities and earnings reactions, Tickeron’s AI Screener has proven helpful for quickly filtering peers by industry, fundamentals, and technical signals. It surfaces relevant ideas efficiently and supports more informed comparisons during reporting seasons like this one.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SBS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


SBS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on August 11, 2026

SBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 30 cases where SBS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SBS as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SBS turned negative on July 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

SBS moved below its 50-day moving average on July 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SBS crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SBS entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.886) is normal, around the industry mean (3.301). P/E Ratio (10.196) is within average values for comparable stocks, (27.095). SBS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.696). SBS has a moderately low Dividend Yield (0.007) as compared to the industry average of (0.032). P/S Ratio (2.079) is also within normal values, averaging (5.494).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

Industry description

Water utilities operate water treatment plants, and/or distribute water to residential and commercial customers. Companies operating in this industry are largely responsible for the safe and timely distribution of water. While most water systems are local or regional, some of the companies might have operations across several states. The industry is expected to be closely monitored by regulators for quality checks on the water being distributed. Investing in upgrading infrastructure is a major factor in bolstering the supply of clean/safe-to-use water. Given the absolute necessity of water in our lives, the industry is largely non-cyclical. American Water Works Company, Inc., Aqua America, Inc., American States Water Co. and California Water Service Group are some of the major water utilities companies in the U.S.

Market Cap

The average market capitalization across the Water Utilities Industry is 5.27B. The market cap for tickers in the group ranges from 41.88K to 27.12B. AWK holds the highest valuation in this group at 27.12B. The lowest valued company is AEPT at 41.88K.

High and low price notable news

The average weekly price growth across all stocks in the Water Utilities Industry was 4%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 2%. GWRS experienced the highest price growth at 19%, while SBS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Water Utilities Industry was 59%. For the same stocks of the Industry, the average monthly volume growth was 52% and the average quarterly volume growth was 11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 49
Price Growth Rating: 50
SMR Rating: 78
Profit Risk Rating: 85
Seasonality Score: -38 (-100 ... +100)
View a ticker or compare two or three
SBS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of water, sewage and industrial wastewater systems

Industry WaterUtilities

Profile
Details
Industry
Water Utilities
Address
Rua Costa Carvalho, 300
Phone
+55 1133888247
Employees
11170
Web
https://www.sabesp.com.br
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.